BLOOM ENERGY CORP- A (BE)

US0937121079 - Common Stock

12.0201  +0.58 (+5.07%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BE. BE was compared to 86 industry peers in the Electrical Equipment industry. BE has a bad profitability rating. Also its financial health evaluation is rather negative. BE is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

BE had negative earnings in the past year.
In the past year BE has reported a negative cash flow from operations.
BE had negative earnings in each of the past 5 years.
In the past 5 years BE reported 4 times negative operating cash flow.

1.2 Ratios

The Return On Assets of BE (-12.52%) is comparable to the rest of the industry.
BE has a Return On Equity (-60.19%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -12.52%
ROE -60.19%
ROIC N/A
ROA(3y)-12.51%
ROA(5y)-14.31%
ROE(3y)-82.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BE's Gross Margin of 14.84% is on the low side compared to the rest of the industry. BE is outperformed by 65.48% of its industry peers.
BE's Gross Margin has declined in the last couple of years.
BE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.23%
GM growth 5Y-2.02%

3

2. Health

2.1 Basic Checks

BE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BE has been increased compared to 1 year ago.
BE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BE is higher compared to a year ago.

2.2 Solvency

BE has an Altman-Z score of -0.56. This is a bad value and indicates that BE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.56, BE is doing worse than 63.10% of the companies in the same industry.
A Debt/Equity ratio of 2.50 is on the high side and indicates that BE has dependencies on debt financing.
With a Debt to Equity ratio value of 2.50, BE is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.5
Debt/FCF N/A
Altman-Z -0.56
ROIC/WACCN/A
WACC9.97%

2.3 Liquidity

BE has a Current Ratio of 3.60. This indicates that BE is financially healthy and has no problem in meeting its short term obligations.
BE has a Current ratio of 3.60. This is amongst the best in the industry. BE outperforms 80.95% of its industry peers.
BE has a Quick Ratio of 2.53. This indicates that BE is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BE (2.53) is better than 84.52% of its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 2.53

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.22% over the past year.
The Revenue has grown by 11.21% in the past year. This is quite good.
The Revenue has been growing by 16.08% on average over the past years. This is quite good.
EPS 1Y (TTM)62.22%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-74.07%
Revenue 1Y (TTM)11.21%
Revenue growth 3Y18.86%
Revenue growth 5Y16.08%
Revenue growth Q2Q-22.85%

3.2 Future

The Earnings Per Share is expected to grow by 85.66% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.86% on average over the next years. This is a very strong growth
EPS Next Y154.69%
EPS Next 2Y114.64%
EPS Next 3Y85.66%
EPS Next 5YN/A
Revenue Next Year2.27%
Revenue Next 2Y12.66%
Revenue Next 3Y17.81%
Revenue Next 5Y22.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BE. In the last year negative earnings were reported.
BE is valuated quite expensively with a Price/Forward Earnings ratio of 129.28.
Based on the Price/Forward Earnings ratio, BE is valued a bit cheaper than the industry average as 64.29% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BE to the average of the S&P500 Index (20.72), we can say BE is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 129.28

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BE's earnings are expected to grow with 85.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.64%
EPS Next 3Y85.66%

0

5. Dividend

5.1 Amount

BE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLOOM ENERGY CORP- A

NYSE:BE (5/3/2024, 8:47:02 AM)

12.0201

+0.58 (+5.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.71B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 129.28
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.52%
ROE -60.19%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 14.84%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 2.5
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.6
Quick Ratio 2.53
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)62.22%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y154.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.21%
Revenue growth 3Y18.86%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y